<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855606</url>
  </required_header>
  <id_info>
    <org_study_id>PrEP@PIMAN</org_study_id>
    <nct_id>NCT02855606</nct_id>
  </id_info>
  <brief_title>Acceptability of HIV Oral PrEP Among MSM and TGW</brief_title>
  <official_title>Acceptability of HIV Oral Pre-Exposure Prophylaxis (PrEP) Among Men Have Sex With Men (MSM) and Transgender Women (TGW)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiang Mai University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiang Mai University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the factors associated with acceptability to oral
      HIV pre-exposure prophylaxis (PrEP) among Thai men who have sex with men (MSM) and
      transgender women (TGW).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability and factors affecting the decision to take oral PrEP</measure>
    <time_frame>1 year</time_frame>
    <description>After receiving information about PrEP, the participants will have a chance to decide whether they want to take PrEP or not. The set of questions asking about reason(s) for taking (or not taking) PrEP are used to evaluated the acceptability. The questions will evaluate multiple aspects such as knowledge about PrEP (efficacy and medications side effect), personal belief about PrEP, sexual practice, social stigmata, and concern for HIV resistance. The participants will answer these questions via Computer-Assisted Self Interviewing (CASI).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to PrEP by self-report</measure>
    <time_frame>1 year</time_frame>
    <description>Among the participants who decide to take PrEP, the adherence will be evaluate by self-report (directly to medical staff and via Computer-Assisted Self Interviewing).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to PrEP by pill count</measure>
    <time_frame>1 year</time_frame>
    <description>Among the participants who decide to take PrEP, the adherence will be evaluate by pill count.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Patient Acceptance of Health Care</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Thai MSM and TGW
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MSM or TGW at age18 years or older at enrollment

          -  Able to read and write effectively in Thai language

          -  Negative HIV testing (by assigned rapid tests) at enrollment

          -  Available to return for the study visits and willing to comply with study requirements

          -  Willing to provide reachable contact numbers and address

          -  Creatinine clearance â‰¥ 60 mL/min

          -  Negative urine protein

          -  Negative HBs Ag

        Exclusion Criteria:

          -  Symptoms suggestive for acute HIV seroconversion

          -  Participating in any interventional HIV research

          -  Has any physical or mental condition(s) that, in the opinion of the investigator(s),
             complicate interpretation of study outcome data
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suwat Chariyalertsak, MD. DrPH.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Institute for Health Sciences (RIHES)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suwat Chariyalertsak, MD. DrPH.</last_name>
    <phone>66-53-936148</phone>
    <phone_ext>109</phone_ext>
    <email>suwat@rihes.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Piman Center</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radhcanok Songsupa</last_name>
      <phone>6653211 363</phone>
    </contact>
    <contact_backup>
      <last_name>Pongpun Saokhieo</last_name>
    </contact_backup>
    <investigator>
      <last_name>Quanhathai Kaewpoowat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chiang Mai University</investigator_affiliation>
    <investigator_full_name>Suwat Chariyalertsak</investigator_full_name>
    <investigator_title>MD., Dr.PH</investigator_title>
  </responsible_party>
  <keyword>Oral PrEP</keyword>
  <keyword>TGW</keyword>
  <keyword>Thai MSM</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

